What is OutSense?
OutSense Diagnostics is a pioneering health-tech firm that has engineered an innovative IoT-enabled medical device designed to transform standard toilet bowls into sophisticated diagnostic tools. By autonomously scanning human waste, the platform provides real-time, actionable health insights to caregivers and medical professionals. This non-invasive approach to patient monitoring facilitates the early detection of various medical conditions, effectively bridging the gap between routine biological output and clinical data.
Beyond individual patient care, the company is building a comprehensive database on human excretions. This unique repository of biological data is poised to support personalized healthcare initiatives and accelerate medical research. By targeting healthcare providers, public health organizations, and pharmaceutical entities, OutSense is redefining the utility of waste analysis, turning routine biological data into a vital asset for lifesaving medical interventions.
How much funding has OutSense raised?
OutSense has raised a total of $2.2M across 1 funding round:
Series A
$2.2M
Series A (2020): $2.2M with participation from Peregrine Ventures
Key Investors in OutSense
Peregrine Ventures
Peregrine is dedicated to advancing medical innovation through global strategic investments, focusing on life science companies at various stages of development. The company leverages deep industry knowledge and a synergetic strategy to support portfolio companies in bringing groundbreaking healthcare technologies to market.
What's next for OutSense?
With this major strategic investment, OutSense is well-positioned to accelerate its commercial deployment and expand its footprint within the global healthcare market. The company's roadmap likely includes scaling its manufacturing capabilities, enhancing its diagnostic algorithms through machine learning, and forging deeper partnerships with pharmaceutical companies for clinical trial support.
As the healthcare industry shifts toward proactive, data-driven models, OutSense's ability to provide continuous, non-intrusive monitoring will be a key differentiator. The firm is expected to focus on regulatory milestones and the integration of its platform into existing hospital and long-term care workflows, ensuring that its diagnostic insights become a standard component of patient management protocols.
